High cholesterol despite taking statins? Cardiologist Dr Naveen Bhamri explains who may benefit from cholesterol-lowering injections and how they work.
Novo Nordisk's Wegovy subcutaneous injection gets approval in Japan for MASH: Osaka, Japan Monday, June 22, 2026, 14:00 Hrs [IST] Sumitomo Pharma Co., Ltd announced that Novo Nord ...
Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing ...
Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on multiple studies, including the pivotal IRAKLIA phase 3 study which demonstrated ...
Health authorities have said the long-acting antiretroviral drug, Lenacapavir (LEN) is expected dramatically improve patient ...
The future of weight loss treatment is looking to get easier to swallow. Several research teams and pharmaceutical companies ...
The buzz around GLP-1 medications like Zepbound and Wegovy has changed the way Canadians think about weight loss. Obesity is a chronic disease and nearly one in three (33%) of Canadians between 18 and ...
Sanofi gets approval for Sarclisa subcutaneous formulation in Japan: Paris Monday, June 22, 2026, 13:00 Hrs [IST] The Ministry of Health, Labour and Welfare in Japan has granted a ...
Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen currently under evaluation in fully enrolled Phase ...
That would be an impressive run if it could get there soon.
Joseph K. Han, MD, discusses upstream biologics, verekitug, and the future of chronic rhinosinusitis with nasal polyps treatment. Verekitug (Upstream Bio), used to treat patients with chronic ...
Sanofi's Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on multiple studies, including the pivotal IRAKLIA phase 3 study which demonstrated non-i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results